Literature DB >> 2989171

The contribution of vasopressin and angiotensin to the maintenance of blood pressure after autonomic blockade.

M Hiwatari, P L Nolan, C I Johnston.   

Abstract

The contribution of vasopressin and angiotensin II to the maintenance of blood pressure after short-term autonomic blockade was investigated in conscious Long-Evans and Brattleboro (vasopressin-deficient; hereditary diabetes insipidus) rats. After short-term autonomic blockade by atropine (1 mg/kg), propranolol (5 mg/kg), and pentolinium (5 mg/kg and 10 mg/kg/hr), the fall in blood pressure was significantly greater in Brattleboro rats than in Long-Evans rats (48 +/- 3 vs 32 +/- 2 mm Hg; p less than 0.01). Administration of the vasopressin vascular receptor antagonist D(CH2)5Tyr-(Me)AVP (2 micrograms/kg) caused further blood pressure decreases only in Long-Evans rats, so that the final blood pressure in both groups was identical. Administration of enalaprilat (10 mg/kg), an angiotensin converting enzyme inhibitor, further reduced blood pressure in both strains. When enalaprilat was given first after autonomic blockade, it reduced blood pressure in Brattleboro rats but not in Long-Evans rats. Administration of the vasopressin antagonist after enalaprilat further reduced blood pressure only in Long-Evans rats. The fall in blood pressure following vasopressin blockade was greater than that occurring after angiotensin converting enzyme inhibition (14 +/- 1 vs 6 +/- 1 mm Hg; p less than 0.05) in autonomic blockade Long-Evans rats. Plasma levels of vasopressin in Long-Evans rats increased markedly after short-term autonomic blockade, whereas plasma renin and angiotensin II levels were unchanged. Plasma angiotensin II levels were increased by the vasopressin antagonist and decreased by enalaprilat. We conclude that, due to sympathetic nervous system blockade and consequent blunting of renal renin release, vasopressin has a greater capacity than the renin-angiotensin system for maintaining blood pressure after short-term autonomic blockade.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2989171     DOI: 10.1161/01.hyp.7.4.547

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  5 in total

1.  Intrapulmonary bronchial circulation during hemorrhage.

Authors:  M Nakai; M Kawamura; T Kunieda; Y Yamane; Y Umeda; M Inada
Journal:  Heart Vessels       Date:  1991       Impact factor: 2.037

Review 2.  National Heart, Lung, and Blood Institute Working Group Report on Salt in Human Health and Sickness: Building on the Current Scientific Evidence.

Authors:  Young S Oh; Lawrence J Appel; Zorina S Galis; David A Hafler; Jiang He; Amanda L Hernandez; Bina Joe; S Ananth Karumanchi; Christine Maric-Bilkan; David Mattson; Nehal N Mehta; Gwendolyn Randolph; Michael Ryan; Kathryn Sandberg; Jens Titze; Eser Tolunay; Glenn M Toney; David G Harrison
Journal:  Hypertension       Date:  2016-06-20       Impact factor: 10.190

3.  Baroreflex resetting but no vascular tolerance in response to transdermal glyceryl trinitrate in conscious rabbits.

Authors:  A P Serone; J A Angus; C E Wright
Journal:  Br J Pharmacol       Date:  1996-05       Impact factor: 8.739

4.  Impaired blood pressure compensation following hemorrhage in conscious obese Zucker rats.

Authors:  Lusha Xiang; John S Clemmer; Silu Lu; Peter N Mittwede
Journal:  Life Sci       Date:  2013-06-16       Impact factor: 5.037

5.  Prevention of hypotension induced by combined spinal epidural anesthesia using continuous infusion of vasopressin: A randomized trial.

Authors:  Chetna Shamshery; Ashish Kannaujia; Rajashree Madabushi; Dinesh Singh; Divya Srivastava; Shobhana Jafa
Journal:  Anesth Essays Res       Date:  2016 Sep-Dec
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.